EUVIMEDEUVIMED entdecken
Crossref

Targeting the Association between Interarm Blood Pressure Difference and Subclinical Organ Damage: Findings from the PAMELA Study

Cesare Cuspidi iD, Rita Facchetti iD, Fosca Quarti-Trevano iD, Marijana Tadic iD, Jennifer Vanoli, Giuseppe Mancia iD, Guido Grassi

American Journal of Hypertension · 2025

DOI: 10.1093/ajh/hpaf207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Cesare Cuspidi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy. Hauptthemen laut MEDLINE: Hypertrophy, Left Ventricular, Blood Pressure, Hypertension. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence on the association of interarm difference (IAD) in BP with subclinical cardiac and vascular damage in community-based populations is scanty. We addressed this issue in the participants to the Pressioni Monitorate E Loro Associazioni (PAMELA) study.

Methods

The study included 527 participants who attended the third survey of the PAMELA study performed after 25 years from the initial evaluation. Data collection included medical history, anthropometric parameters, blood examinations, office BP, simultaneous IAD assessment, echocardiographic and cardio-ankle velocity index (CAVI) measurements.

Results

In the whole study sample (age 66 ± 10 years, 49% males), the prevalence of systolic IAD (ie, IASD ≥ 10 mm Hg) was 12%. Although the association between IASD and left ventricular hypertrophy (LVH) (OR = 2.45, P = .007) disappeared after adjustment for several factors, this abnormal BP phenotype was twice as high in participants with LVH compared to those with normal LV geometry (21.7% vs 10.2%, P < .01). Furthermore, the prevalence of IASD in participants with LVH and LV remodeling was overall 3 times higher than in their normal counterparts. As for vascular damage, no relationship emerged between IASD with CAVI, treated either as a categorical (ie, CAVI > 9 m/second) or continuous variable.

Conclusions

Our study provides a new piece of evidence on the value of IASD as a potential marker of LVH, which in turn reflects the burden of several coexisting cardiovascular risk factors. From a practical perspective, the detection of IASD could be a clinical rationale for investigating subclinical cardiac organ damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertrophy, Left VentricularBlood PressureHypertensionHumansMaleAgedFemaleMiddle AgedPrevalenceVentricular RemodelingRisk FactorsCross-Sectional StudiesBlood Pressure DeterminationAsymptomatic DiseasesCardio Ankle Vascular IndexAnkle Brachial IndexItaly

Stichwörter der Autor:innen

arterial stiffnessblood pressurehypertensioninterarm blood pressure differenceleft ventricular hypertrophy

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
  • University Heart Center Ulm, University Ulm, Ulm, Germany.

ORCID-Profile: Cesare Cuspidi, Rita Facchetti, Fosca Quarti-Trevano, Marijana Tadic, Giuseppe Mancia

Zitieren

APA

Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Tadic, M., Vanoli, J., Mancia, G., & Grassi, G. (2025). Targeting the Association between Interarm Blood Pressure Difference and Subclinical Organ Damage: Findings from the PAMELA Study. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf207

Vancouver

Cuspidi C, Facchetti R, Quarti-Trevano F, Tadic M, Vanoli J, Mancia G, et al. Targeting the Association between Interarm Blood Pressure Difference and Subclinical Organ Damage: Findings from the PAMELA Study. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf207

BibTeX
@article{Cuspidi2025,
  author = {Cuspidi, Cesare and Facchetti, Rita and Quarti-Trevano, Fosca and Tadic, Marijana and Vanoli, Jennifer and Mancia, Giuseppe and Grassi, Guido},
  title = {Targeting the Association between Interarm Blood Pressure Difference and Subclinical Organ Damage: Findings from the PAMELA Study},
  journal = {American Journal of Hypertension},
  year = {2025},
  doi = {10.1093/ajh/hpaf207}
}
Kostenlos starten →